Background-A significant association between vascular calcification and osteoporosis has been noted, suggesting that calcium homeostasis is important in vascular calcification as well as in osteoporosis. 
C alcification is almost invariably associated with atherosclerotic plaque formation. [1] [2] [3] Recently, it was hypothesized that plaque calcification is an active, regulated process similar to osteogenesis. 4 Bone morphogenetic proteins (BMPs), including BMP-2, and bone matrix proteins, such as osteopontin (OPN), osteonectin, and osteocalcin, have been demonstrated in atherosclerotic plaques, especially calcified lesions, through immunohistochemistry and in situ hybridization. [5] [6] [7] [8] [9] However, details of the mechanism by which vascular calcification is induced remain unclear. Using an in vitro model of vascular calcification, we demonstrated that the expression of alkaline phosphatase (ALP) is functionally important in the calcification of bovine vascular smooth muscle cells (BVSMCs) and that OPN mRNA is expressed exclusively in calcified BVSMCs. 10 Therefore, it is likely that vascular smooth muscle cells (VSMCs) acquire calcifying capacity under certain conditions. Vascular calcification often occurs in women with osteoporosis. [11] [12] [13] [14] Moreover, there is an inverse relationship between the degree of vascular calcification and bone mineral content, suggesting that calcium homeostasis is important in atherosclerotic calcification as well as in osteoporosis. 15 
Methods

Reagents
Media, FBS, and sodium pyruvate were purchased from GIBCO. ␤-Glycerophosphate (␤-GP) was obtained from Sigma Chemical Co. 1,25(OH) 2 D 3 was obtained from Solvay Duphar BV. Human PTHrP (fragment 1-34) was obtained from Peptide Institute. Human PTHrP cDNA probe containing a 451-base pair fragment (corresponding to Ϫ5 to 446 in its full-length cDNA 16 ) was a kind gift of Dr M. Hino (Department of Clinical Hematology, Osaka City University Medical School, Osaka, Japan). Unless otherwise mentioned, all other reagents were obtained from Wako Pure Chemical Industries, Ltd.
Cell Culture and In Vitro Calcification
BVSMCs were obtained by explantation as previously described. 10 Cells that had migrated from the explants were collected and maintained in DMEM (high glucose, 4.5 g/L glucose) containing 15% FBS and 10 mmol/L sodium pyruvate supplemented with 100 U/mL penicillin and 100 g/mL streptomycin (growing medium) at 37°C in a humidified atmosphere containing 5% CO 2 . Cells up to passage 8 were used for the experiments. BVSMC calcification was induced as previously described. 10 Briefly, BVSMCs were cultured in the growing medium. After confluence, the cells were inoculated in DMEM (high glucose, 4.5 g/L) containing 15% FBS and 10 mmol/L sodium pyruvate in the presence of 10 mmol/L ␤-GP supplemented with 100 U/mL penicillin and 100 g/mL streptomycin (calcification medium) for 72 hours.
Quantification of Calcium Deposition
Cells were decalcified with 0.6N HCl for 24 hours. The calcium content of HCl supernatant was determined colorimetrically by the o-cresolphthalein complexone method (calcium C-test Wako; Wako Pure Chemical Industries). 16 After decalcification, cells were washed 3 times with PBS and solubilized with 0.1N NaOH/0.1% SDS. Protein content was measured with a BCA protein assay kit (Pierce). Calcium content of the cell layer was normalized by protein content.
Measurement of PTHrP
We assessed secretion of PTHrP by BVSMCs by measuring the PTHrP content of the culture supernatant with an immunoradiometric assay kit (PTHrP IRMA kit; Mitsubishi Kagaku). 16 The supernatant was collected in the presence of 10 g/mL aprotinin and 1 mmol/L EDTA after the fresh medium containing 15% FBS was incubated for 72 hours with BVSMCs on a six-well plate. The content of PTHrP in the medium containing 15% FBS incubated for 72 hours without the cells was estimated as the background. The net quantity of PTHrP secreted from BVSMCs was estimated by subtracting the PTHrP content of the background from that in the cell culture supernatant. Finally, the data were normalized by the protein content of the cell layer.
ALP Assay
After the cells were washed twice with PBS, the cellular proteins were solubilized with 1% Triton X-100 in 0.9% NaCl and centrifuged, and the supernatants were assayed for ALP activity as described previously. 10 One unit was defined as the activity producing 1 nmol of p-nitrophenol for 30 minutes. Protein concentrations were determined with a BCA protein assay kit (Pierce).
RNA Isolation and Northern Blot Analysis
Total RNA was isolated from BVSMCs by extraction with acid guanidinium thiocyanate-phenol-chloroform. Twenty micrograms of total RNA was electrophoresed onto 1% agarose gels containing formaldehyde and transferred to a nylon filter (Hybond N; Amersham International). Blots were prehybridized at 37°C for 24 hours in a buffer containing 50% formamide, 3ϫ SSC (1ϫ SSC, 0.15 mol/L NaCl, and 15 mmol/L sodium citrate, pH 7.4), 50 mmol/L Tris-HCl, pH 7.5, 0.1% SDS, 20 g/mL denatured salmon sperm DNA, and 1ϫ Denhardt's solution and then hybridized at 37°C for 48 hours with cDNA probes for human PTHrP or bovine OPN that were labeled with [␣-32 P]dCTP (3000 Ci/mL; New England Nuclear Research Products) by use of a random priming method (Megaprime cDNA labeling system, Amersham). Blots were washed and autoradiographed with x-ray film at Ϫ70°C. The amounts of RNA were quantified by densitometric scanning and normalized by comparison with GAPDH.
Statistics
In certain experiments, data were analyzed for statistical significance by ANOVA with posthoc analysis (Fisher's protected least significant difference [PLSD] ). These analyses were performed with the assistance of a computer program (StatView Version 4.11; Abacus Concepts).
Results
We first examined the effect of 1,25(OH) 2 D 3 on BVSMC calcification. 1,25(OH) 2 D 3 promoted this calcification in a dose-dependent manner, and the calcium content of the cell layer increased to 470% of the calcified control at 10 -7 mol/L (Figure 1 ). Because ALP plays an important role in BVSMC calcification, as previously reported, 10 we next examined the effect of 1,25(OH) 2 D 3 on ALP activity in BVSMCs. As we previously reported, ALP activities were increased in each group in the presence of ␤-GP (calcified condition) compared with its absence (uncalcified condition) 10 ( Figure 2 ). 1,25(OH) 2 D 3 dose dependently increased ALP activities in both uncalcified and calcified BVSMCs, and at 10 -7 mol/L, ALP activities increased to 168% and 167% of the control, respectively (Figure 2 ). These data suggest that the stimulatory effect of 1,25(OH) 2 D 3 on calcification may be due to increased ALP activity.
Because we have demonstrated that PTHrP secreted from BVSMCs acts as an endogenous inhibitor of vascular calcification, 16 we next examined the effect of 1,25(OH) 2 D 3 on PTHrP secretion by BVSMCs. PTHrP secretion was decreased in each group in the presence of ␤-GP (calcified condition) compared with its absence (uncalcified condition) (Figure 3) , as previously reported. 16 
Discussion
In this study, we demonstrated a possible mechanism by which 1,25(OH) 2 D 3 stimulates vascular calcification through a direct action on VSMCs. Although it has been well documented that a high dose of vitamin D induces vascular calcification in humans and experimental animals, [21] [22] [23] the mechanism of its stimulatory action in vivo on vascular calcification remains to be clarified. We recently demonstrated that PTHrP secreted by VSMCs acts as an endogenous inhibitor of vascular calcification. 16 Therefore, we hypothesized that PTHrP is one of the molecular targets of the action of 1,25(OH) 2 D 3 on VSMCs. As shown in the present study, 1,25(OH) 2 D 3 directly modulates the expression of PTHrP in BVSMCs at both protein and gene levels, contributing to its action on vascular calcification (Figures 3, 4a, and 5) . Therefore, it is likely that VSMCs are equipped with an autocrine/paracrine system that regulates calcium metabolism and that 1,25(OH) 2 D 3 affects this local system to exert its stimulatory action on vascular calcification.
It has been demonstrated that 1,25(OH) 2 D 3 suppresses PTHrP gene transcription in various types of cells, such as rat osteosarcoma cell line (ROS 17/2.8), human squamous cell line (NCI H520), and human keratinocytes. 24 -26 The PTHrP gene has an inhibitory vitamin D response element within its promoter region, which can interact with a vitamin D receptor/retinoid X-receptor heterodimer. 24 Therefore, the inhibitory action of 1,25(OH) 2 D 3 on PTHrP gene expression in BVSMCs, as shown in this study, may be exerted by the same mechanism. However, the precise mechanism of its action should be clarified.
As shown in this study, 1,25(OH) 2 D 3 increased expression of the OPN gene (Figure 4b ) as well as in vitro calcification by BVSMCs. We have previously demonstrated that expression of the OPN gene is dramatically increased in calcified BVSMCs. 10 In our preliminary experiments, recombinant OPN dose dependently increased this calcification (Jono et al, unpublished observation, 1997 An association between osteoporosis and vascular calcification with aging has been well documented in several studies. [11] [12] [13] [14] Vitamin D deficiency is common in the elderly and may contribute to bone loss by causing increased levels of PTH. 34, 35 Therefore, it is presumed that vitamin D deficiency may be involved in the pathogenesis of vascular calcification. Recently, it was reported that active serum vitamin D levels are inversely correlated with coronary calcification. 20 This finding seems to suggest the protective roles of vitamin D in vascular calcification and to support the above-mentioned hypothesis. However, the vast majority of its values presented in the study were within normal range, 20 and serum levels of 25-hydroxyvitamin D (25OHD), a serum marker for nutritional status of vitamin D, were not documented. Therefore, it is not clear whether vitamin D deficiency may contribute to such inverse correlation. Further studies are necessary to confirm the hypothesis.
Because vitamin D and calcium supplementation are widely used for the treatment of osteoporosis, especially in the elderly, 36 it is important to determine whether long-term supplementation of vitamin D for osteoporosis exacerbates vascular calcification. It is suggested from the present study that pharmacological doses of 1,25(OH) 2 D 3 may stimulate vascular calcification through a direct action on VSMCs. However, high doses of oral vitamin D, which induces vascular calcification in experimental animals, do not always increase serum levels of 1,25(OH) 2 D, but 25OHD is increased, 15, 37, 38 because the serum level of 1,25(OH) 2 D is strictly regulated within the narrow range by PTH, regardless of the nutritional status of vitamin D. The mechanism by which increased levels of serum 25OHD induce vascular calcification remains to be clarified. Local production of 1,25(OH) 2 D by 1␣-hydroxylase expressed in macrophages accumulated in atherosclerotic lesions may be involved in this process. 39 Therefore, it is important to monitor serum levels of 25OHD during vitamin D supplementation. If serum levels of 25OHD are increased beyond the normal range, vascular calcification may develop even within normal levels of 1,25(OH) 2 D.
